Dapagliflozin (5mg), Metformin (500mg)
May 09, 2023
Dapagliflozin (5mg), Metformin (500mg)
GLIDAPAFLOZIN M medications are used to treat type 2 diabetes.
Dapagliflozin belongs to a class of medications called SGLT2 inhibitors. It works by blocking the reabsorption of glucose by the kidneys, causing glucose to be excreted in the urine and lowering blood glucose levels. Dapagliflozin can also help with weight loss and reduce the risk of cardiovascular events in people with type 2 diabetes.
Metformin belongs to a class of medications called biguanides. It works by reducing the amount of glucose produced by the liver and improving the body's response to insulin, a hormone that helps regulate blood glucose levels. Metformin is often used as a first-line medication for type 2 diabetes and can also help with weight loss.
GLIDAPAFLOZIN M are sometimes prescribed as a combination therapy to help control blood glucose levels in people with type 2 diabetes. GLIDAPAFLOZIN M can provide complementary benefits and may be more effective than either medication alone. As with any medication, it's important to talk to your healthcare provider about the potential benefits and risks of taking GLIDAPAFLOZIN M, as well as any other medications or supplements you may be taking.
For further information please contact: contact@sterispharma.com
Order now: https://www.sterisonline.com/product/glidapaflozin-m-5-500-133424
Recent Post

Spironolactone Tablet – Uses , Dosage, Precautions & Side Effects

Tenofovir Disoproxil Fumarate Tablets IP 300 mg: Uses,Dosage & Side Effects

Danazol 200 mg: Uses, Composition, Indications & Side Effects

The Rise of Digital Health in Pharma: How Telemedicine, Apps, and Wearables Are Changing Patient Care

Danazol 100 mg: Uses, Mechanism of Action & Side Effects

Danazol 50 mg Capsule: Uses, Benefits & Side Effects

Vonoprazan 20 mg Tablet Uses, Side Effects & Mechanism of Action

Vonoprazan 10 mg Tablet Uses, Side Effects & Dosage

Mycophenolate Mofetil 500 mg - Uses, Side Effects & Dosage

Global Trends Shaping Pharma in 2025